Pediatric Diabetes

Papers
(The TQCC of Pediatric Diabetes is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
154
Can HbA1c Alone Be Safely Used to Guide Insulin Therapy in African Youth with Type 1 Diabetes?146
Household Food Insecurity and Cognition in Youth and Young Adults with Youth-Onset Diabetes143
Risk Factors for Hyperosmolar Hyperglycemic State in Pediatric Type 2 Diabetes113
Glucose Variability and Postprandial Hyperglycaemia After Breakfast in Children and Young People With Type 1 Diabetes102
Ongoing Increase in Incidence of Diabetes in Austrian Children and Adolescents (1989–2021): Results from a Nationwide Registry92
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15‐Year Retrospective Study from a Regional Center in New Zealand84
Three‐variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes74
Are we confident that final‐year medical students know at least basics about diabetes?: A preliminary report from the multicenter, survey‐based Diabetes Know‐Me stud68
Telemedicine and COVID ‐19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world‐wide cross‐sectional web‐based survey66
Aortic intima media thickness in children and adolescents with type 1 diabetes: A systematic review65
A collaborative comparison of international pediatric diabetes registries61
Development and psychometric analysis of the D iabetes D evice C onfidence S56
ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes54
Metabolomics and Lipidomics Studies in Pediatric Type 1 Diabetes: Biomarker Discovery for the Early Diagnosis and Prognosis51
Longitudinal progression of diabetes mellitus in Wolfram syndrome: The Washington University Wolfram Research Clinic experience50
46
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results39
39
Exome sequencing in children with clinically suspected maturity‐onset diabetes of the young38
Physical activity and progression to type 1 diabetes in children and youth with islet autoimmunity: The diabetes autoimmunity study in the young35
Beta cell function, incretin hormones, and incretin effect in obese children and adolescents with prediabetes35
ISPAD Clinical Practice Consensus Guidelines 2022: Editorial30
Effectiveness of Educational and Psychoeducational Self‐Management Interventions in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta‐Analysis29
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers28
Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program28
27
ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in children and adolescents with diabetes27
Caries experience and gingival health in children and adolescents with type 1 diabetes mellitus—A cross‐sectional study25
A longitudinal assessment of diabetes autoantibodies in the SEARCH for diabetes in youth study24
Non‐surgical Treatment May be Appropriate for Most Chinese Children With Monogenic Congenital Hyperinsulinism Based on a Retrospective Study of 121 Patients23
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents22
Complications during Adolescence Predict Mortality in Young Adults with Childhood Onset Type 1 Diabetes21
Oral Abstract20
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery20
Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first‐degree relatives of patients with type 1 diabetes19
Natural history and determinants of dysglycemia in Canadian children with parental obesity from ages 8–10 to 15–17 years: The QUALITY 19
The metabolic syndrome is frequent in children and adolescents with type 1 diabetes compared to healthy controls18
ISPAD Annual Conference 2022 highlights18
Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry17
Situational Awareness and Proactive Engagement Predict Higher Time in Range in Adolescents and Young Adults Using Hybrid Closed-Loop16
DNA Methylation Near DLGAP2 May Mediate the Relationship between Family History of Type 1 Diabetes and Type 1 Diabetes Risk16
The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes15
Effects of interrupting daily sedentary behavior on children's glucose metabolism: A 6‐day randomized controlled trial15
Internet‐delivered eating disorders prevention program for adolescent girls with type 1 diabetes: Acceptable and feasible15
Type 1 diabetes diagnosed before age 15 years in Canterbury, New Zealand: A 50 year record of increasing incidence15
Up all night? Sleep disruption in parents of young children newly diagnosed with type 1 diabetes15
Improved genetic risk scoring algorithm for type 1 diabetes prediction14
Good glycemic control without exceeding the BMI trajectory during the first 5 years of treatment in children and adolescents with type 1 diabetes14
Type 1 diabetes in Laos, 2016–202113
13
Etiologic Determinants and Characteristics of Diabetes in Haitian Youth (EDDHY Study)13
Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes13
Disparities in Glycemic Outcomes Persist in Youth with Type 1 Diabetes and High-Technology Use13
HbA1c percentiles and the association between BMI , age, gender, puberty, and HbA1c levels in healthy Germa13
Mortality amongst children and adolescents with type 1 diabetes in sub‐Saharan Africa: The case study of the Changing Diabetes in Children program in Cameroon13
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents12
Type 1 Diabetes and Other Autoimmune Disorders in Children12
Indicators of glucose dysregulation and the relationship with iron overload in Chinese children with beta thalassemia major12
Predictive Value of 1-Hour Glucose Elevations during Oral Glucose Tolerance Testing for Cystic Fibrosis-Related Diabetes12
Issue Information12
The Psychometric Properties of the Type 1 Diabetes Mellitus Screening Acceptability Assessment (DMSA) Scale among General Population12
Corrigendum11
Clinical characteristics, growth patterns, and long‐term diabetes complications of 24 patients with neonatal diabetes mellitus: A single center experience11
Issue Information11
Predictors of mood, diabetes‐specific and COVID ‐19‐specific experiences among parents of early school‐age children with type 1 diabetes during initial months of the11
Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study11
Issue Information11
Optimized simplified pediatric diabetes severity warning system for the early identification of diabetic ketoacidosis in children11
Tubular injury in diabetic ketoacidosis: Results from the diabetic kidney alarm study10
Clinical Characterization of Data-Driven Diabetes Clusters of Pediatric Type 2 Diabetes10
Pancreatic beta‐cell function dynamics in youth with GCK , HNF1A 10
The role of protective psychological factors, self‐care behaviors, and HbA1c in young adults with type 1 diabetes10
Real‐World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes10
Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes—A Danish nationwide cohort study10
Markers of Early Liver Dysfunction Associate With Reduced Heart Rate Variability in Adolescents With Type 1 Diabetes10
Issue Information10
Splitting Mealtime Insulin Doses for Mixed Fat and Protein Meals in Children and Adolescents with Type 1 Diabetes Using Multiple Daily Injection Regimen: A Randomized Cross-Over Trial9
9
ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes9
Hispanic Caregivers' experience of pediatric type 1 diabetes: A qualitative study9
Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting9
A Late Meal Timing Pattern Is Associated with Insulin Resistance in European Children and Adolescents9
Development of a Multivariable Risk Prediction Tool to Predict Adverse Outcomes among Children with Type 1 Diabetes: A Pilot Study9
Comparisons of School-Day Glycemia in Different Settings for Children with Type 1 Diabetes Using Continuous Glucose Monitoring9
Adverse Social Determinants of Health in Children with Newly Diagnosed Type 1 Diabetes: A Potential Role for Community Health Workers9
Evolution of Cardiovascular Risk Factors Related to BMI and Metabolic Control in Children and Adolescents With Type 1 Diabetes Mellitus: A Cohort Study8
Clinical presentation and long‐term outcome of patients with KCNJ11 / ABCC8 8
School-Based Diabetes Care: A National Survey of U.S. Pediatric Diabetes Providers8
Extremely Early Appearance of Islet Autoantibodies in Genetically Susceptible Children8
Risk of substance use disorders among adolescents and emerging adults with type 1 diabetes: A population‐based cohort study8
Type 1 diabetes incidence increased during the COVID ‐19 pandemic years 2020–2021 in Czechia: Results from a large population‐based pediatric register8
Assessment of cognitive function in young children with type 1 diabetes mellitus using electrophysiological tests8
Survival of children and youth with type 1 diabetes mellitus in Tanzania8
Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes8
0.27101302146912